Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:433-438

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulter, V.
Right arrow Articles by Kostner, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulter, V.
Right arrow Articles by Kostner, G. M.
Related Collections
Right arrow Angiogenesis
Right arrow Risk Factors
Right arrow Fibrinolysis
Right arrow Fibrinogen/fibrin
Right arrow Coagulation and fibronolysis
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:433.)
© 2001 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Impact of Apolipoprotein(a) on In Vitro Angiogenesis

V. Schulter; P. Koolwijk; E. Peters; S. Frank; A. Hrzenjak; W. F. Graier; V. W. M. van Hinsbergh; G. M. Kostner

From the Institute of Medical Biochemistry and Medical Molecular Biology (V.S., S.F., A.H., W.F.G., G.M.K.), Karl-Franzens-University, Graz, Austria, and the Gaubius Laboratory (P.K., E.P., V.W.M.v.H.), TNO Prevention and Health, Leiden, The Netherlands.

Correspondence to Prof Dr Gerhard M. Kostner, Institute of Medical Biochemistry and Medical Molecular Biology, Harrachgasse 21/III, 8010 Graz, Austria. E-mail gerhard.kostner{at}kfunigraz.ac.at

Abstract—Angiostatin, which consists of the kringle I–IV domains of plasminogen and which is secreted into urine, is an efficient inhibitor of angiogenesis and tumor growth. Because N-terminal apolipoprotein(a) [apo(a)] fragments, which also contain several types of kringle IV domains, are found in urine as well, we evaluated the potential angiostatic properties of these urinary apo(a) fragments and of a recombinant form of apo(a) [r-apo(a)]. We used human microvascular endothelial cell (hMVEC)–based in vitro assays of tube formation in 3-dimensional fibrin matrixes. Purified urinary apo(a) fragments or r-apo(a) inhibited the basic fibroblast growth factor/tumor necrosis factor-{alpha}–induced formation of capillary-like structures. At concentrations varying from 0.2 to 10 µg/mL, urinary apo(a) fragments inhibited tube formation by as much as 70%, whereas there was complete inhibition by r-apo(a). The highest concentrations of both inhibitors also reduced urokinase plasminogen activator production of basic fibroblast growth factor–induced hMVEC proliferation. The inhibitors had no effect on plasminogen activator inhibitor-1 expression. If our in vitro model for angiogenesis is valid for the in vivo situation as well, our data point toward the possibility that apo(a) may also be physiologically operative in modulating angiogenesis, as the concentration of free apo(a) found in humans exceeds that tested herein.


Key Words: Lp(a) • endothelial cells • kringle • urinary fragments




This article has been cited by other articles:


Home page
Cancer Res.Home page
H.-K. Yu, J.-S. Kim, H.-J. Lee, J.-H. Ahn, S.-K. Lee, S.-W. Hong, and Y. Yoon
Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles
Cancer Res., October 1, 2004; 64(19): 7092 - 7098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Ahn, J.-S. Kim, H.-K. Yu, H.-J. Lee, and Y. Yoon
A Truncated Kringle Domain of Human Apolipoprotein(a) Inhibits the Activation of Extracellular Signal-regulated Kinase 1 and 2 through a Tyrosine Phosphatase-dependent Pathway
J. Biol. Chem., May 21, 2004; 279(21): 21808 - 21814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Kim, J.-H. Chang, H.-K. Yu, J.-H. Ahn, J.-S. Yum, S.-K. Lee, K.-H. Jung, D.-H. Park, Y. Yoon, S.-M. Byun, et al.
Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)
J. Biol. Chem., August 1, 2003; 278(31): 29000 - 29008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser
Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints
Am. J. Pathol., October 1, 2001; 159(4): 1445 - 1453.
[Abstract] [Full Text]